Pneumococcal Vaccine Schedules Acquisition-Immunogenicity
- Conditions
- Pneumococcal acquisition and vaccine immunogenicity
- Registration Number
- PACTR202105670402672
- Lead Sponsor
- ondon School of Hygiene and Tropical Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 784
Resident in the study area
Age 0-10 weeks
Intention to reside in cluster until 18 months of age
Intent to move out of the study area before 18 months of age
Age greater than 10 weeks
Prematurity <34 weeks gestation
Birth weight <2.0kg or weight <2.5 kg
History of invasive bacterial infection or measles
Receiving long-term antibiotic therapy, i.e. greater than 4 weeks
HIV infection in the infant or mother
Chronic debilitating illness
Immunosuppressive therapy or immunodeficiency disorder
Contraindication to PCV13 – severe hypersensitivity to a previous dose of PCV13
Contraindication to YF vaccine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method